Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1955 2
1956 2
1957 4
1958 1
1959 3
1960 2
1961 13
1962 36
1963 32
1964 25
1965 34
1966 57
1967 43
1968 48
1969 41
1970 34
1971 38
1972 41
1973 25
1974 31
1975 22
1976 33
1977 32
1978 55
1979 55
1980 70
1981 73
1982 97
1983 88
1984 98
1985 124
1986 122
1987 127
1988 142
1989 160
1990 148
1991 167
1992 190
1993 191
1994 196
1995 208
1996 277
1997 281
1998 273
1999 239
2000 313
2001 283
2002 325
2003 356
2004 345
2005 319
2006 338
2007 369
2008 356
2009 368
2010 378
2011 406
2012 514
2013 492
2014 535
2015 562
2016 612
2017 536
2018 545
2019 578
2020 661
2021 754
2022 699
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

13,526 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives.
Papamichael K, Afif W, Drobne D, Dubinsky MC, Ferrante M, Irving PM, Kamperidis N, Kobayashi T, Kotze PG, Lambert J, Noor NM, Roblin X, Roda G, Vande Casteele N, Yarur AJ, Arebi N, Danese S, Paul S, Sandborn WJ, Vermeire S, Cheifetz AS, Peyrin-Biroulet L; International Consortium for Therapeutic Drug Monitoring. Papamichael K, et al. Among authors: kobayashi t. Lancet Gastroenterol Hepatol. 2022 Feb;7(2):171-185. doi: 10.1016/S2468-1253(21)00223-5. Lancet Gastroenterol Hepatol. 2022. PMID: 35026171 Review.
The Reply.
Auwaerter PG, Kobayashi T, Wormser GP. Auwaerter PG, et al. Among authors: kobayashi t. Am J Med. 2022 Feb;135(2):e56-e57. doi: 10.1016/j.amjmed.2021.09.025. Am J Med. 2022. PMID: 35148822 No abstract available.
The Reply.
Auwaerter PG, Kobayashi T, Wormser GP. Auwaerter PG, et al. Among authors: kobayashi t. Am J Med. 2022 Mar;135(3):e78-e79. doi: 10.1016/j.amjmed.2021.10.035. Am J Med. 2022. PMID: 35249634 No abstract available.
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis.
Marra AR, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto BM, Bariani LM, Auler MA, Salinas JL, Edmond MB, Doll M, Kutner JM, Pinho JRR, Rizzo LV, Miraglia JL, Schweizer ML. Marra AR, et al. Among authors: kobayashi t. J Infect. 2022 Mar;84(3):297-310. doi: 10.1016/j.jinf.2021.12.035. Epub 2022 Jan 1. J Infect. 2022. PMID: 34982962 Free PMC article. Review.
Paraurachal paraganglioma.
Tsuruta M, Goto T, Kono J, Kita Y, Masui K, Sano T, Fujimoto M, Sawada A, Akamatsu S, Kobayashi T. Tsuruta M, et al. Among authors: kobayashi t. IJU Case Rep. 2022 May 31;5(5):358-361. doi: 10.1002/iju5.12488. eCollection 2022 Sep. IJU Case Rep. 2022. PMID: 36090947 Free PMC article.
Retraction Note to: Clinical significance of perineural invasion diagnosed by immunohistochemistry with anti-S100 antibody in Stage I-III colorectal cancer.
Shimada Y, Kido T, Kameyama H, Nakano M, Yagi R, Tajima Y, Okamura T, Nakano M, Nagahashi M, Kobayashi T, Minagawa M, Kosugi SI, Wakai T, Ajioka Y. Shimada Y, et al. Among authors: kobayashi t. Surg Today. 2022 Mar;52(3):519. doi: 10.1007/s00595-022-02466-y. Surg Today. 2022. PMID: 35124763 No abstract available.
13,526 results
You have reached the last available page of results. Please see the User Guide for more information.